In this case report, we discussed a manic episode that developed after including trazodone for sleep problems in the treatment of a patient with an anxiety disorder who uses escitalopram.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Antidepressants with hypnotic effects can often be added to treatment for sleep prob-lems emerging in patients receiving antidepressant treatment.
📊
Key Findings & Data:One of these is trazodone, which is an antidepressant that exhibits hypnotic effect by the effect of histamine H1 re-ceptor antagonist and 5-HT2A stimulation, which is a serotonin transporter protein inhib-itor and 5-HT2A and 5HT2C antagonist.
💡
Conclusion & Impact:In this case report, we discussed a manic episode that developed after including trazodone for sleep problems in the treatment of a patient with an anxiety disorder who uses escitalopram.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Antidepressants with hypnotic effects can often be added to treatment for sleep prob-lems emerging in patients receiving antidepressant treatment. One of these is trazodone, which is an antidepressant that exhibits hypnotic effect by the effect of histamine H1 re-ceptor antagonist and 5-HT2A stimulation, which is a serotonin transporter protein inhib-itor and 5-HT2A and 5HT2C antagonist. Some antidepressants can cause mania-like mood episodes when used singly or in combination. In this case report, we discussed a manic episode that developed after including trazodone for sleep problems in the treatment of a patient with an anxiety disorder who uses escitalopram.
🔖
Cite This Article
İZCİ, F., YOLCU, S., ÜLGER, E. (2022). Manic Episode as a Result of Adding Trazodone to a Patient under Escitalopram Treatment. Alpha psychiatry (Online), Cilt: 22 - Sayı: 1, 67–69. https://ajindex.com/articles/435199
Satetia MJ. Update on sleep and psychiatric disorders. Chest. 2009
135(5):1370-1379. [Crossref] 2. Hu J, Lai J, Zheng H, et al. Fan the flame: trazo-done-induced mania in a unipolar depressed patient with stable sertraline treatment. Neuropsychiatr Dis Treat. 2017
[Crossref] 3. Stahl SM. Mechanism of action of trazodone: a multi-functional drug. CNS Spectr. 2009
14(10):536-546. [Crossref] 4. Fagiolini A, Comandini A, Dell’Osso MC, et al. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012
26(12):1033-1049. [Crossref] 5. Wong J, Motulsky A, Abrahamowicz M, et al. Off label indications for anti-depressants in primary care: descriptive study of pre-scripttions from an indication based electronic prescribing system. BMJ. 2017
[Crossref] 7. Prapotnik M, Waschgler R, König P, et al. Therapeutic drug monitoring of trazodone: are there pharmacokinetic interactions involving citalopram and fluoxetine? Int J Clin Pharmacol Ther. 2004
42(2):120-124. [Crossref] 8. Wichniak A, Wierzbicka A. The effects of antidepressants on sleep in depressed patients with particular reference to trazodone in comparison to agomelatine, amitriptyline, doxepin, mianserine and mirtazapine. Pol Merkur Lekarski. 2011
31(181):65-70. 9. Bernardo NG. Mania associated with mirtazapine aug-mentation of fluoxetine. Depress Anxiety. 2002
15(1):46-47. [Crossref] 10. Liu CC, Liang KY, Liao SC. Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features. J Psychopharmacol. 2009
23(2):220-222. [Crossref] 11. Wichniak A, Wierzbicka A, Jernajczyk W. Sleep and antidepressant treatment. Curr Pharm Des. 2012
18(36):5802-5817. [Crossref] 12. Wichniak A, Jarkiewicz M, Okruszek Ł, et al. Low risk for switch to mania during treatment with sleep promoting antidepressants. Pharmacopsychiatry. 2015
48(3):83-88. [Crossref] 13. Baldessarini RJ, Faedda GL, Offidani E, et al. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord. 2013
148(1):129-135. [Crossref] 14. Koszewska I, Rybakowski JK. Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Neuropsychobiology. 2009